A phase 3, randomized, double-blind comparison of analgesic efficacy and tolerability of Q8003 vs Oxycodone or morphine for moderate-to-severe postoperative pain following bunionectomy surgery

Pain Medicine (United States)

Volumn 14, Issue 8, 2013, Pages 1230-1238

  Richards, Patricia ^a   Riff, Dennis ^b   Kelen, Robin ^a   Stern, Warren ^a  

^a QRxPharma Inc   (United States)

^b Advanced Clinical Research Institute   (United States)

Author keywords

Acute Pain; Morphine; Opioid; Opioid Related Side Effects; Oxycodone; Postoperative Pain; Q8003

Indexed keywords

IBUPROFEN; MORPHINE; MORPHINE PLUS OXYCODONE; OXYCODONE; Q 8003; UNCLASSIFIED DRUG; DRUG COMBINATION; MOXDUO; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANALGESIC ACTIVITY; ARTICLE; BUNIONECTOMY; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HEADACHE; HOSPITAL PATIENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; VITAL SIGN; VOMITING; ADOLESCENT; AGED; BIOASSAY; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG COMBINATION; ETHNIC GROUP; HALLUX VALGUS; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ENDPOINT DETERMINATION; ETHNIC GROUPS; FEMALE; HALLUX VALGUS; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; MORPHINE; OXYCODONE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; YOUNG ADULT;

EID: 84882728850     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12167     Document Type: Article

References (27)

1. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004;100:1573-1581.
2. Gregorian RS, Gasik A, Kwong WJ, Voeller S, Kavanagh S. Importance of side effect in opioid treatment: A trade-off analysis with patients and physicians. J Pain 2010;11:1-14.
3. Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: A systematic review. J Pain 2002;3:159-180.
4. Boswell K, Kwong WJ, Kavanagh S. Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: A systematic literature review. J Opioid Manag 2010;6:269-289.
5. Federal Register Notice Docket number FDA-2011-N-0021-0001.
6. Pasternak GW. Molecular insights into mu opioid pharmacology: From the clinic to the bench. Clin J Pain 2010;26(suppl 10):S3-9.
7. Ross FB, Wallis SC, Smith MT. Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain 2000;84:421-428.
8. Smith MT. Differences between and combinations of opioids re-visited. Curr Opin Anaesthesiol 2008;21:596-601.
9. Bolan EA, Tallarida RJ, Pasternak GW. Synergy between mu opioid ligands: Evidence for functional interactions among mu opioid receptor subtypes. J Pharmacol Exp Ther 2002;303:557-562.
10. Pasternak GW. Preclinical pharmacology and opioid combinations. Pain Med 2012;13(suppl 1):S4-11.
11. Blumenthal S, Min K, Marquardt M, Borgeat A. Postoperative intravenous morphine consumption, pain scores, and side effects with perioperative oral controlled-release oxycodone after lumbar discectomy. Anesth Analg 2007;105:233-237.
12. Webster L, Richards P, Stern W, Kelen R; MoxDuo Study Group. A double-blind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain. J Opioid Manag 2010;6:329-340.
13. Stern W, Kelen R, Riff D, Richards P. Treatment of post-operative pain with a dual opioid combination of morphine and oxycodone: Analgesia and side effects. Abstract PH326 Presented at the 13th World Congress of Pain, August 31, 2010, Montreal, Quebec, Canada.
14. ® (morphine plus oxycodone) in patients with moderate to severe pain following total knee arthroplasty. Presented at the American Pain Society 30th Annual Meeting, May 17-19, 2011, Austin, Texas.
15. Richards P, Minkowitz H, Gimbel J, Kelen R. An active controlled evaluation of the efficacy and safety of dual opioid treatment with morphine plus oxycodone for acute pain following total knee arthroplasty. Abstract PH330 Presented at the 13th World Congress of Pain, August 31, 2010, Montreal, Quebec, Canada.
16. ®) in the treatment of postoperative pain. J Opioid Manag 2011;7:217-228.
17. ® (morphine plus oxycodone) relative to morphine alone or oxycodone alone on respiratory depression in a post-surgical setting. Presented at the American Pain Society 30th Annual Meeting, May 17-19, 2011, Austin, Texas.
18. ® (morphine: oxycodone combination) produces less oxygen desaturation than equi-analgesic doses of either morphine or oxycodone alone in subjects with postoperative pain following bunionectomy. Poster #269 presented at the American Academy of Pain Medicine Annual Meeting, February 24, 2012, Palm Springs, California.
19. Myles PS, Chrystelis N. Measuring pain and analgesic response. Eur J Anaesthesiol 2011;28:399-400.
20. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: A validation study. J Pain Symptom Manage 2003;25:406-411.
21. Chang AK, Bijur PE, Napolitano A, Lupow J, Gallagher EJ. Two milligrams i.v.hydromorphone is efficacious for treating pain but is associated with oxygen desaturation. J Opioid Manag 2009;5:75-80.
22. Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer 2003;89:2027-2030.
23. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine 1998;23:2591-2600.
24. Oderda G. Challenges in the management of acute postsurgical pain. Pharmacotherapy 2012;32(9 Pt 2):6S-11S.
25. Barletta JF. Clinical and economic burden of opioid use for postsurgical pain: Focus on ventilatory impairment and ileus. Pharmacotherapy 2012;32(9 Pt 2):12S-18.
26. Suh DC, Kim MS, Chow W, Jang EJ. Use of medications and resources for treatment of nausea, vomiting, or constipation in hospitalized patients treated with analgesics. Clin J Pain 2011;27:508-517.
27. Barletta JF, Asgeirsson T, Senagore AJ. Influence of intravenous opioid dose on postoperative ileus. Ann Pharmacother 2011;45:916-923.